The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 12%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (5 analysts) rates it strong buy, with a mean price target of $60.
Carriage Services Inc
CSV · the NYSE · USD · Market cap $598M · 1,248 employees
Carriage Services, Inc.
FAIL · Does not pass the screenPrice as of 19 Nov 2026Daily close, not a live quote
Screened 2026-11-19 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price29.50 USD at the 19 Nov 2026 close
- Fair valueUnder review: our model's value is 2.22x the price, above our 2.00x limit.
- Our regime readDistribution, as of 15 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans heavily to calls (put/call 0.23)
- Last reviewed19 Nov 2026 (1 day ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: range not available (screen dated 2026-11-19).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.23, read 2026-11-15
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
Carriage Services Inc holds its Distribution at $29.50. Consolidating, no directional conviction, held for 6 days.
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 6 days |
| Price at the screen | $29.50 |
| Valuation | 11.23 trailing · 8.21 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 0.84 |
Five Screens: CSV's Results
FAIL. Debt ratio
| Test | Figure | Limit | Status |
|---|---|---|---|
| Business activity | Permissible | Permissible core business | Pass |
| Debt load | 41.05% | Below 33% | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Pass |
| Receivables | 3.00% | Below 49% | Pass |
Definitions, sources and threshold rules: ticker values-screen methodology.
The Ethical ReadWhy It Falls Short, in Plain English
Carriage Services's business is in a permissible area, but its interest-bearing debt is about 41% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when CSV's ethical verdict changes
Today CSV does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Fair value under review. Our model's value is 2.22x the price, above our 2.00x limit. We show no fair value, margin of safety or value read built on it until the review clears.
Model construction and limits: fair-value methodology.
The Street's RangeThird-party analyst targets. The average target sits +103% from the screen price.
Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-19 screen.
How our estimate and third-party targets differ.
The Business, in Plain Words| Forward P/E | 8.2xvery cheap relative to earnings |
| Trailing P/E | 11.2xreasonably valued |
| EPS, trailing | 2.75 |
| EPS, forward | 3.76 |
| Revenue growth | -0.9%revenue is shrinking |
| Profit margin | 10.6%thin but positive margins |
| Return on equity | 18.0%a solid return on shareholder capital |
| FCF yield | 7.57% |
| Dividend yield | 1.18% |
| Debt to equity | 2.05heavy leverage: higher risk if revenue softens |
| Current ratio | 1.15adequate liquidity, worth monitoring |
| Beta | 0.84steadier than the market |
| Short interest, float | 0.04% |
| 52-week range | 37.11 - 52.10 |
| Moat | NONE |
| Market cap | $598M |
| Employees | 1,248 |
CSV-specific watchpoints · The things to watch: it's a small-cap, so the share price can swing harder than the market; it carries a real debt load, which raises the stakes if revenue slips.
Metric definitions and interpretation rules: ticker-page methodology.
Every Entry, As Written
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 14.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 12%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (5 analysts) rates it strong buy, with a mean price target of $60.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 1.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 12%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (5 analysts) rates it strong buy, with a mean price target of $60. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 12%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (5 analysts) rates it strong buy, with a mean price target of $60. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 12%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (5 analysts) rates it strong buy, with a mean price target of $60. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 1.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 12%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (5 analysts) rates it strong buy, with a mean price target of $60. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 12%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (5 analysts) rates it strong buy, with a mean price target of $60. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 12%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (5 analysts) rates it strong buy, with a mean price target of $60. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 2.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 12%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (5 analysts) rates it strong buy, with a mean price target of $60. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 12%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (5 analysts) rates it strong buy, with a mean price target of $60. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $34.98 | -16.2% | $0.11 | $841 | -15.9% |
| 2 months | $30.38 | -3.5% | $0.11 | $968 | -3.2% |
| 3 months | $34.42 | -14.8% | $0.11 | $855 | -14.5% |
| 6 months | $43.47 | -32.6% | $0.23 | $679 | -32.1% |
| 1 year | $40.39 | -27.4% | $0.45 | $737 | -26.3% |
| 2 years | $38.02 | -22.9% | $0.90 | $795 | -20.5% |
| 3 years | $21.76 | +34.7% | $1.36 | $1,410 | +41.0% |
| 5 years | $48.42 | -39.5% | $2.26 | $652 | -34.8% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever CSV does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.